Skip to main content
Clinical Trials/NCT02546037
NCT02546037CompletedNot Applicable

Pilot Study to Determine the Effect of Different Dialyzer Membranes on Clotting During Haemodiafiltration Treatments in Patients With Chronic Kidney Disease

University College, London0 sites10 target enrollmentStarted: September 30, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Primary Endpoint
convective volume exchanged

Study Overview

Brief Summary

Primary Objective:

The purpose of this study is to measure the amount of convection achieved with two different haemodiafilters designed for haemodiafiltration and clotting during haemodiafiltration treatment.

Detailed Description

This is a prospective observational cohort pilot study of patients under the care of the Royal Free Hospital with chronic kidney disease who have been established on regular thrice weekly haemodiafiltration treatments in a dialysis centre. Information on the study will be disseminated to the Royal Free consultant nephrologists at the dialysis centre with primary responsibility for the individual patient.

Study Design

Study Type
Observational
Observational Model
Case Crossover
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients age 18 years and older up to 80 years
  • Under the care of the Royal Free Hospital with chronic kidney disease and established on regular thrice weekly haemodiafiltration.
  • Able to provide written informed consent obtained

Exclusion Criteria

  • Patients scheduled for a kidney transplant
  • Patients taking concomitant systemic anticoagulants
  • Patients with known prothrombotic or bleeding disorders
  • Patients with abnormal platelet counts
  • Patients unable to provide written informed consent
  • Patients not fulfilling inclusion criteria

Outcomes

Primary Outcomes

convective volume exchanged

Time Frame: day 1

volume of convective exchange achieved during the HDF session

Secondary Outcomes

  • visual coagulation(day 1)
  • platelet and coagulation pathway activation(day 1)
  • small and middle sized solute clearances(day 1)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Clotting With Different Dialyzer Membranes | Clinical Trial